Izlaganje sa skupa

PHYSICAL HEALTH CHECKS IN PATIENTS ON ANTIPSYCHOTIC MEDICATION

Gloria Lau ; School of Clinical Medicine, University of Cambridge, Cambridge, UK
Juliette Murphy ; School of Clinical Medicine, University of Cambridge, Cambridge, UK
Natasha Chaudhury ; School of Clinical Medicine, University of Cambridge, Cambridge, UK
Mark Agius ; Centre for Mental Health Research in Association with the University of Cambridge, Cambridge, UK

Sažetak

Schizophrenic patients have traditionally suffered from high rates of cardiovascular disease and early mortality. NICE
guidelines suggest that several physical health measures be monitored regularly in these patients, and particularly those on
antipsychotic medication, which has a wide side-effect profile that may potentiate the risk of cardiovascular disease and other
comorbidities. This general practice audit aimed to determine the rates of physical health monitoring in primary care in patients on
antipsychotic medication for over a year for psychotic symptoms or schizophrenia. The search was conducted in three different
general practices in March 2019, yielding 19, 8 and 30 patients respectively, with a total of 57 patients.
This audit aims to record and analyse rates of monitoring of a range of physical health measures recommended by NICE
guidelines over the past year. The results demonstrated that physical health monitoring was poor amongst all the practices audited,
especially that of prolactin and waist circumference. We recommend that these rates of monitoring be improved, through
implementing templates or the delivery of targeted education to general practitioners and nurses.

Ključne riječi

audit; antipsychotic medication; cardiovascular side effects; cardiovascular risk; psychosis; schizophrenia; hyperprolactinaemia

Hrčak ID:

264207

URI

https://hrcak.srce.hr/264207

Datum izdavanja:

4.9.2019.

Posjeta: 474 *